Synthetic studies of ecteinascidin 743 and fennebricin B

Ecteinascidin 743 (Et-743, trabectidin or Yondelis®) possesses an impressive antitumor activity that it was approved for treatments of several cancer types worldwide. Since this natural product only presents as a trace amount in the nature, the main supply of this drug for research and commercial use is from laboratory synthesis. Many syntheses of Et-743 have been reported including three total syntheses, two formal syntheses and two semisyntheses. The biological activities of fennebricin B were unknown due to the scarcity of this natural product. However, fennebricin B share a common pentacyclic core with Et-743, thus may also possess interesting biological activities. Our group completed our formal synthesis of the natural product in 2008, featuring the Pictet-Spengler reaction to construct the pentacyclic core of Et-743. Our work, however, also produced both desired and undesired pentacycle without selectivity. We herein described an improved formal synthesis of Et-743 employing bromine auxiliary to generate the pentacylic core of Et-743 with the desired regioisomer as the only product. This approach was also utilized in the synthetic studies toward the total synthesis of fennebricin B.

Name thesis:degree_name

Doctor of Philosophy (Ph.D.)

Level thesis:degree_level

Doctoral

Discipline thesis:degree_discipline

Chemistry

Grantor dc:publisher

Colorado State University. Libraries

Year dc:date.issued

2017

Authors dc:creator

• Le, Vy Hoang, author
• Williams, Robert M., advisor
• Kennan, Alan J., committee member
• Finke, Richard G., committee member
• Luger, Karolin, committee member

Statement dc:rights

• Copyright and other restrictions may apply. User is responsible for compliance with all applicable laws. For information about copyright law, please see https://libguides.colostate.edu/copyright.

Language dc:language.iso

eng, English

Identifier URI

https://doi.org/10.25675/3.018790

OAI identifier oai:identifier

oai:mountainscholar.org:10217/185626